Preventing and responding to chemo extravasation at the bedside
Original source title: ONS Guidance: Safe Handling and Vesicant Extravasation Management
Brief summary
ONS guidance reinforces safe chemotherapy administration and vesicant extravasation management: confirm access, monitor the site, recognize extravasation early, and follow the agent-specific response. Oncology nurses prevent and catch these events at the bedside.
What NurseJet pulled from the source
ONS guidance on chemotherapy and biotherapy administration reinforces the safe-handling and vesicant-management practices that protect both patients and nurses. Vesicants can cause severe tissue injury if they leak into surrounding tissue, so prevention, early recognition, and a prepared response are emphasized.
The guidance covers verifying a patent vascular access device, monitoring the site during administration, recognizing extravasation early (burning, swelling, loss of blood return, or resistance), and following a defined response: stop the infusion, aspirate, and apply the antidote or thermal measure appropriate to the agent.
For oncology nurses, the message is preparation plus vigilance: know which agents are vesicants, watch the site continuously, and have your extravasation kit and protocol ready before you start. Early recognition limits tissue damage and is squarely a bedside nursing responsibility.
Why this matters for nurses
Extravasation can cause lasting tissue damage, but most harm is preventable with vigilant monitoring and a fast, correct response. Oncology nurses control the access checks, site monitoring, and immediate response that determine the outcome.
Key takeaways
- Vesicants can cause severe tissue injury if they extravasate — prevention and early recognition are key.
- Verify a patent access device and monitor the site throughout administration.
- Early signs: burning, swelling, loss of blood return, or resistance to infusion.
- Response: stop, aspirate, and apply the agent-specific antidote/thermal measure per protocol.
Practice implications
- Confirm blood return and line patency before and during vesicant administration.
- Keep the extravasation kit and agent-specific protocol accessible before starting.
- Educate patients to report any burning, stinging, or swelling at the site immediately.
Nursing assessment
- Vascular access patency, blood return, and site appearance throughout infusion.
- Patient-reported burning, pain, or stinging at the site.
- Knowledge of which ordered agents are vesicants versus irritants.
Patient safety
- Loss of blood return or new site pain during a vesicant infusion is an emergency — stop immediately.
- Antidotes and thermal measures are agent-specific; using the wrong one can worsen injury.
Patient & family education
- Tell patients to report any burning, pain, or swelling at the IV site right away.
- Explain why the nurse checks the site so frequently during treatment.
Limitations & cautions
- Protocols are agent-specific and follow facility policy and the drug reference.
- Demo content is illustrative — verify specifics against current ONS guidance.
Citations
Exact source links
Public citations are filtered to exact approved source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Oncology Nursing Society — Chemotherapy/biotherapy safe-handling and extravasation resources.
Oncology Nursing Society
https://www.ons.org/clinical-tools/pep/extravasation-management
Professional education only